---
title: "Rigel制药 (RIGL.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RIGL.US/norm.md"
symbol: "RIGL.US"
name: "Rigel制药"
parent: "https://longbridge.com/zh-CN/quote/RIGL.US.md"
datetime: "2026-05-20T17:07:52.514Z"
locales:
  - [en](https://longbridge.com/en/quote/RIGL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RIGL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RIGL.US/norm.md)
---

# Rigel制药 (RIGL.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.4400 | 13.55 | 1.46 | 3.28 | 0.6300 |
| ROE | 8.75% | 421.25% | 111.86% | 474.53% | 418.98% |
| 营业收入 | 58.82M | 69.80M | 69.46M | 101.69M | 53.33M |
| 净利润 | 8.65M | 268.06M | 27.90M | 59.61M | 11.45M |
| 营业利润 | 11.88M | 23.17M | 28.42M | 61.10M | 12.77M |
| 毛利率 | 72.32% | 76.16% | 82.57% | 88.86% | 75.92% |
| 净利率 | 14.71% | 384.04% | 40.17% | 58.63% | 21.46% |
| 利润含金量 | 436.15% | 105.41% | 118.26% | 200.09% | -1430.35% |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 504.61M | 513.59M | 242.53M | 206.74M | 175.97M |
| 权益乘数 | 1.26 | 1.31 | 2.06 | 2.52 | 9.48 |
| 每股净资产 | 21.64 | 21.38 | 6.48 | 4.57 | 1.04 |
| 资产周转率 | 0.8809 | 0.8686 | 1.48 | 1.60 | 1.34 |
| 现金及短投 | 146.68M | 154.96M | 137.14M | 108.38M | 77.10M |
| 存货与应收 | 25.06M | 23.36M | 20.61M | 15.83M | 16.39M |
| 长期投资 | 785000.00 | 950000.00 | 1.10M | 1.24M | 1.38M |
| 净债务 | -100.96M | -101.65M | -76.26M | -47.34M | 23.95M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | 2.73M | 21.98M | 24.03M | 30.54M | -893000.00 |
| 投资现金流 | -7.97M | -25.36M | -33.17M | -23.28M | -10.55M |
| 融资现金流 | -10.92M | -4.57M | 4.27M | 418000.00 | 484000.00 |
| 自由现金流 | -470875.00 | 15.18M | 11.23M | 56.92M | -4.15M |
| 现金流充裕率 | 36.33% | 293.54% | 200258.33% | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | 12000.00 | -12000.00 | - | - |